4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bausch Health Companies Inc. (BHC) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Laval, Canada with about 20,300 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, BHC reported $10.3B in revenue and $157M in net income.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
Interactive charts & full statements → Open the BHC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $10.3B | $9.6B | $8.8B | $8.1B | — |
| Gross Profit | $7.3B | $6.8B | $6.2B | $5.8B | — |
| Operating Income (EBIT) | $2.2B | $1.9B | $1.6B | $1.4B | — |
| Net Income | $157M | ($46M) | ($592M) | ($225M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $2.5B | $2.8B | $2.7B | $2.5B | $2.3B |
| Gross Profit | $1.8B | $2.0B | $1.9B | $1.8B | $1.6B |
| Operating Income (EBIT) | $521M | $829M | $636M | $457M | $292M |
| Net Income | ($1.4B) | ($112M) | $179M | $148M | ($58M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | — | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $26.4B | $26.5B | $27.4B | $25.7B | — |
| Total Liabilities | $26.0B | $26.8B | $27.4B | $25.4B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BHC viewer.
About TickerBase · Data methodology & sources